RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Dong Liang to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Dong Liang has written about Xenograft Model Antitumor Assays.
Dong Liang
Connection Strength
0.029
Xenograft Model Antitumor Assays
  1. Liang S, Bian X, Liang D, Sivils JC, Neckers LM, Cox MB, Xie H. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016; 21(1):121-6.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support